Name: immunity to and prevention of herpes zoster (en Inglés)
Price: 83950.00 CLP
Availability: InStock
Author: Gershon, A. A. ; Calisher, C. H. ; Arvin, A. M.
ISBN: 9783211835555

portada immunity to and prevention of herpes zoster (en Inglés)

Formato

Libro Físico

Ilustrado por

Editorial

Autor

Gershon, A. A. ; Calisher, C. H. ; Arvin, A. M.

Año

2001

Idioma

Inglés

N° páginas

184

Encuadernación

Tapa Blanda

Dimensiones

27.2 x 20.8 x 0.8 cm

Peso

0.54 kg.

ISBN

3211835555

ISBN13

9783211835555

Categorías

Enfermedades infectocontagiosas
Microbiología médica y virología
Microbiología (no médica)

immunity to and prevention of herpes zoster (en Inglés)

A. A. Gershon (Ilustrado por) · C. H. Calisher (Ilustrado por) · A. M. Arvin (Ilustrado por) · Springer · Tapa Blanda

Libro Nuevo

$ 83.950

$ 139.910

Ahorras: $ 55.960

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 15 de Mayo y el Viernes 24 de Mayo.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "immunity to and prevention of herpes zoster (en Inglés)"

Under sponsorship of the National Institutes of Health of Japan, an international conference entitled "Immunity and Prevention of Herpes Zoster" was held in 1 Osaka, Japan, March 8-10, 1999. Attendees included basic and clinical investi- gators from Asia, Europe, and North America. The meeting was organized to explore progress made in basic virology and molecular understanding of varicella zoster (VZV), and to provide information on current knowledge of latency of VZV in humans. Updates on the immunology responses of humans to VZV, and a description of the current status of varicella vaccine worldwide were also included. In addition, the possibility of prevent- ing zoster in people latently infected with wild-type VZV by immunizing them with varicella vaccine was presented. The papers in this volume include written summaries of most of the presentations given at that conference. Coincidentally but appropriately, the conference marked the twenty-fifth or "silver anniversary" of the first publication of the development and use of live varicella vaccine to prevent varicella, by Takahashi and his colleagues. Because varicella vaccine is the first herpesvirus vaccine licensed in use for humans, it is of special interest to all individuals who studied these pathogens. In view of the interest in developing vaccines against other herpes viruses, there was also a presentation on the current status of vaccines against cytomegaloviruses (CMV) at the conference.